|
|
|
| Heidelberg Patient & Family Seminar
September 26-28, 2003 |
|
|
|
Where:
Heidelberg, Germany
MEETING OF THE GERMAN-SPEAKING MYELOMA MULTICENTER GROUP (GMMG)
Friday, September 26, 2003
Noon to 5:30 PM |
|
|
|
Overview of GMMG-HD3
|
I. Breitkreutz, Heidelberg
H. Goldschmidt, Heidelberg
|
| Scientific Program GMMG HD3 |
P.Liebisch, Ulm
F.W. Cremer, Heidelberg
R. Bartl, München
B. Klein, Montpellier
|
| Overview of HOVON |
H. Lokhorst, Utrecht |
| Relapse Study TCID |
A. Glasmacher, Bonn
Schmidt-Wolf, Bonn
|
| Relapse Study TCED |
Th. Moehler, Heidelberg |
| Central European Study Group |
H. Ludwig, Wien |
| NMAM-2000 EBMT-Study |
G. Gahrton, Huddinge |
| TPX in Elderly Patients |
W. Knauf, Berlin |
| Revimid-Phase-III-Study |
TBA |
| Velcade-Phase-III-Study |
H. Goldschmidt, Heidelberg |
| Velcade-Phase-II-Study |
Kropf, Muenster |
| Bisphosponates plus IL-2 |
Kunzmann, Wuerzburg |
| Ribomustin plus Thal |
W. Poenisch, Leipzig |
Dinner in Vinery
7:00 pm
|
|
WORKSHOP "NEW DRUGS AND TRANSPLANTATION IN MULTIPLE MYELOMA
Saturday September 27, 2003
8:00 AM to 3:00 PM |
New Drugs in Multiple Myeloma
Chairs: Durie/Bartl/Ho
|
| Thalidomide |
Goldschmidt, Heidelberg
|
| Revimid |
Durie, Los Angeles |
| Velcade |
TBA |
| Arsen |
Ludwig, Wien |
| New Bisphosphonates |
Bartl, München |
|
|
Transplantation of Hematopoietic Cells
Chairs: Gahrton/Lokhorst/Goldschmidt |
| Autologous SCT after HD-Therapy |
Goldschmidt, Heidelberg |
| Autologous SCT after Intermediate Therapy |
TBA |
| Allogeneic SCT after HD-Therapy |
Gahrton, Huddinge |
| Allogenic SCT after Intermediate Therapy |
Kröger, Hamburg |
| Role of T-Cells |
Lokhorst, Utrecht |
|
SEMINAR OF THE INTERNATIONAL MYELOMA FOUNDATION
Saturday September 27,2003
3:00 PM to 7:00 PM
|
| Opening |
A.D. Ho |
| Welcome |
S. Novis |
| A. Waldmannn, J. Brosig |
DLH |
| Diagnosis and Prognostic Factors |
B. Durie |
| Conventional Therapy |
H. Ludwig |
| Autologous Transplantation |
H. Goldschmidt |
| Allogeneic Transplantation |
G. Gahrton |
Dinner at German Cancer Center
7:00 pm
|
|
|
Sunday September 28, 2003,
9:00 AM to 2:00 PM
|
|
|
Bone Disease
|
R. Bartl |
| Anaemia and Supportive Care |
A. Glasmacher |
| Psycho-Oncological Support |
Verres |
| Alternative Treatment Modalities |
TBA |
| New drugs and treatment options |
B. Durie |
| The importance of clinical trials |
Seibert-Grafe |
| Rehabilitation |
Stenzinger |
| Ask the Expert |
All Speakers |
| Closing Remarks |
S. Novis |
|
|
|
|
